LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer trial tests best order of immunotherapy and chemo
Disease control OngoingThis phase 3 study looks at the best way to treat advanced non-squamous non-small cell lung cancer. It compares starting with immunotherapy alone (pembrolizumab) versus starting with immunotherapy plus chemotherapy (pemetrexed and carboplatin). The goal is to see which approach h…
Matched conditions: LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Targeted pill after surgery may extend life for lung cancer patients
Disease control OngoingThis study tests whether taking erlotinib (a targeted therapy pill) after surgery helps people with a specific type of lung cancer (EGFR-mutant) live longer compared to just watching and waiting. About 390 patients with early-stage lung cancer that was fully removed took part. Th…
Matched conditions: LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:41 UTC